Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Talazoparib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer’s Talzenna Fails To Earn FDA Advisory Committee’s Support
    Pfizer’s Talzenna Fails To Earn FDA Advisory Committee’s Support

    23 May 2025

    // BIOSPACE

    https://www.biospace.com/fda/pfizers-talzenna-expansion-fails-to-earn-fda-advisory-committee-support

    BIOSPACE
    23 May 2025
    Share Share
    FDA Advisors Unanimously Reject Pfizer's Talzenna Expansion Bid
    FDA Advisors Unanimously Reject Pfizer's Talzenna Expansion Bid

    22 May 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-advisors-unanimously-snub-pfizers-bid-expand-talzenna-broader-prostate-cancer-population

    FIERCE PHARMA
    22 May 2025
    Share Share
    Pfizer targets broad Talzenna label in prostate cancer
    Pfizer targets broad Talzenna label in prostate cancer

    11 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-targets-broad-talzenna-approval-prostate-cancer-trial-meets-patient-survival-goal

    FIERCE PHARMA
    11 Oct 2024
    Share Share
    NICE reverses its call on Talzenna after Pfizer discount
    NICE reverses its call on Talzenna after Pfizer discount

    19 Jan 2024

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/after-pfizer-offers-discount-nice-gives-thumbs-breast-cancer-drug-talzenna

    Kevin Dunleavy FIERCE PHARMA
    19 Jan 2024
    Share Share
    EC Approves Pfizer’s TALZENNA®with XTANDI® for Prostate Cancer
    EC Approves Pfizer’s TALZENNA®with XTANDI® for Prostate Cancer

    08 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231221936013/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Pfizer's Talzenna wins broader prostate cancer nod than AZ rival
    Pfizer's Talzenna wins broader prostate cancer nod than AZ rival

    21 Jun 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizers-talzenna-snags-broader-prostate-cancer-nod-astrazenecas-parp-remains-hopeful-further

    Angus Liu FIERCE PHARMA
    21 Jun 2023
    Share Share